Bank of New York Mellon Corp bought a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,938,410 shares of the medical research company's stock, valued at approximately $1,974,561,000. Bank of New
Advisors Capital Management LLC purchased a new stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 66,082 shares of the medical research company's stock, valued at approximately
BOK Financial Private Wealth Inc. purchased a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 3,366 shares of the medical research company's stock, valued at approximately $1,689,000. Several other hedge funds and other
Act Two Investors LLC purchased a new position in Thermo Fisher Scientific Inc. (NYSE: TMO) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,710 shares of the medical research company's stock, valued at approximately $3,364,000. Thermo Fisher Scientific makes up
BlackRock Inc. bought a new position in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 30,919,632 shares of the medical research company's stock, valued at approximately $15,501,867,000. BlackRock Inc. owned approximately 8.36%
Baxter Bros Inc. acquired a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 18,827 shares of the medical research company's stock, valued at approximately $9,439,000. Thermo Fisher Scientific makes
Avalon Trust Co purchased a new position in Thermo Fisher Scientific Inc. (NYSE: TMO) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 35,466 shares of the medical research company's stock, valued at approximately $17,781,000. Thermo Fisher Scientific comprises 1.1% of Avalon
On August 17, 2026, we delve into the DCF analysis for Thermo Fisher Scientific Inc (TMO), a company that has shown a mixed price performance recently, with a y
Bryn Mawr Trust Advisors LLC purchased a new stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 4,936 shares of the medical research company's stock, valued at approximately $2,475,000. Other hedge funds also
Cornerstone Capital Inc. purchased a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 49,009 shares of the medical research company's stock, valued at approximately $24,571,000. Thermo Fisher Scientific makes up approximately 2.2%
